Anita Silwal

Assistant Professor

Oklahoma State University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Anita Silwal is an Assistant Professor at Oklahoma State University, USA. Her research focuses on addressing policy-related barriers and facilitators in opioid use disorder treatment, with an emphasis on community-driven approaches and geographic accessibility to treatment options. Recent publications explore various dimensions of the opioid crisis, including stigma, prescriber data, and community communication strategies within the HEALing Communities Study.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (3)

Robert Bohler

Assistant Professor

Georgia Southern University Jiann-Ping Hsu College of Public Health

UNITED STATES

View details

Nicky Lewis

Associate Professor

University of Kentucky

UNITED STATES

View details

Jeffery C Talbert

University of Kentucky

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anita Silwal

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Identifying and responding to policy-related barriers, facilitators, and misunderstandings in the HEALing communities study: A community-driven approach

A multi-method spatial examination of factors associated with changes in geographic accessibility to buprenorphine providers in HEALing communities study states Kentucky, Massachusetts, and Ohio

The impact of buprenorphine prescriber data on geospatial access to treatment in HEALing Communities Study communities, 2022

Understanding the Political Frames of the Opioid Crisis: A Content Analysis of U.S. Senators’ Tweets

Employment industry and opioid overdose risk: A pre- and post-COVID-19 comparison in Kentucky and Massachusetts 2018–2021

Recent Trends in the Utilization of Long-Acting Injectable Buprenorphine in Kentucky

Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention

Policies Relevant to the Healing Communities Study Kentucky Site Implementation

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

Lessons Learned from Developing Tailored Community Communication Campaigns in the HEALing Communities Study

Collaborators (3)

Robert Bohler

Nicky Lewis

Jeffery C Talbert

Make your next move.